1.
Poltorak V, Kravchun N, Gorshunskaya M, Krasova N. Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation). Mìžnarodnij endokrinologìčnij žurnal [Internet]. 2014Mar.18 [cited 2021Oct.22];(1.57):77-89. Available from: http://iej.zaslavsky.com.ua/article/view/76425